Procter & Gamble/Aventis Actonel
Executive Summary
Osteoporosis indication in the U.S. is expected to include prevention and treatment of osteoporosis in men taking long-term corticosteroids as well as the larger post-menopausal female osteoporosis indication. P&G indicates that approval of Actonel in the U.S. is imminent